Chronic Kidney Disease(CKD) Clinical Trials

31 recruitingLast updated: June 18, 2026

There are 31 actively recruiting chronic kidney disease(ckd) clinical trials across 14 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 4, Phase 3. Top locations include Birmingham, Alabama, United States, Chicago, Illinois, United States, Ankara, Turkey (Türkiye). Updated daily from ClinicalTrials.gov.


Chronic Kidney Disease(CKD) Trials at a Glance

31 actively recruiting trials for chronic kidney disease(ckd) are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Birmingham, Chicago, and Ankara. Lead sponsors running chronic kidney disease(ckd) studies include Hacettepe University, Duke University, and Odense University Hospital.

Browse chronic kidney disease(ckd) trials by phase

Treatments under study

About Chronic Kidney Disease(CKD) Clinical Trials

Looking for clinical trials for Chronic Kidney Disease(CKD)? There are currently 31 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Chronic Kidney Disease(CKD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Chronic Kidney Disease(CKD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 31 trials

Recruiting
Phase 1

Adia Med of Winter Park LLC Chronic Kidney Disease Research Study

Kidney Disease, ChronicChronic Kidney DiseaseKidney Disease+2 more
Adia Med of Winter Park LLC100 enrolled1 locationNCT07572890
Recruiting
Not Applicable

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease(CKD)Type 2 DM
Duke University750 enrolled7 locationsNCT06906627
Recruiting
Not Applicable

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease(CKD)Type 2 DM
Duke University420 enrolled7 locationsNCT06906640
Recruiting

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

Heart FailureSarcopeniaOsteoporosis+11 more
Bettina Mittendorfer100 enrolled1 locationNCT07083557
Recruiting

Kidney Function in People With Cystic Fibrosis in the Era of HEMT

Acute Kidney InjuryChronic Kidney Disease(CKD)Cystic Fibrosis (CF)
University of Virginia260 enrolled3 locationsNCT06595420
Recruiting
Phase 1Phase 2

A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)

Chronic Kidney Disease(CKD)
Regeneron Pharmaceuticals56 enrolled10 locationsNCT05092347
Recruiting

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

Chronic Kidney Disease(CKD)
Regeneron Pharmaceuticals20 enrolled9 locationsNCT05106387
Recruiting
Not Applicable

Exercise and Monitoring With Post-Hospitalization Muscle Atrophy to Sustain Intrinsic Capacity and Strength

Chronic Kidney Disease(CKD)
VA Office of Research and Development250 enrolled2 locationsNCT06607913
Recruiting
Not Applicable

Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease

Chronic Kidney Disease(CKD)CKD Stage 1-3
Fu Jen Catholic University Hospital60 enrolled1 locationNCT07493642
Recruiting
Not Applicable

An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease

Chronic Kidney Disease(CKD)
University of Illinois at Chicago40 enrolled1 locationNCT06754280
Recruiting

Multifrequency MRE in Evaluation of Chronic Kidney Diseases

Chronic Kidney Disease(CKD)
Shengjing Hospital200 enrolled1 locationNCT06202235
Recruiting

MEMRI and Kidney Disease

Kidney TransplantAcute Kidney InjuryVasculitis+1 more
University of Edinburgh120 enrolled1 locationNCT06698614
Recruiting
Phase 3

Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

Chronic Kidney Disease(CKD)Uncontrolled Hypertension
University Hospital, Tours720 enrolled40 locationsNCT05732727
Recruiting
Phase 4

A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease

Chronic Kidney Disease(CKD)
Peter Rossing125 enrolled4 locationsNCT07239570
Recruiting
Not Applicable

Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome

Diabetes MellitusStrokeChronic Kidney Disease(CKD)+4 more
Universidade do Porto150 enrolled1 locationNCT07173062
Recruiting

Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens

Obesity and OverweightMetabolic SyndromeHypertension+7 more
Shanghai Changzheng Hospital4,094 enrolled1 locationNCT07043166
Recruiting

Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.

ObesityCardiovascular DiseasesMetabolic Syndrome+5 more
Clindove Research LLC7,000 enrolled1 locationNCT07106879
Recruiting

Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community

Chronic Kidney Disease(CKD)Hyperkalemia
Xiujuan Zang1,890 enrolled1 locationNCT06940414
Recruiting
Not Applicable

The Effect of the Nutraceutical (-)- Epicatechin on Myosteatosis in Patients With Advanced CKD

Chronic Kidney Disease(CKD)Muscle FunctionMyosteatosis+2 more
Karolinska Institutet10 enrolled1 locationNCT06631820
Recruiting
Phase 1

A Study to Evaluate the Safety, Tolerability and PK of SK-08

Chronic Kidney Disease(CKD)
Consun Pharmaceutical Group48 enrolled1 locationNCT07021157